News
People who use GLP-1 weight loss drugs like Ozempic are more likely to suffer from severe acid reflux, or GERD, a new ...
GLP-1 weight-loss drugs are changing how people date and connect. In a nationally representative survey of 2,000 single U.S.
A new study reports that GLP-1 medications may improve low testosterone in men with obesity or type 2 diabetes. The findings ...
After the American Academy of Pediatrics recommended the use of certain GLP-1 weight loss drugs in January of 2023, the use ...
A new report based on national prescription data shows weight-loss drug use is rising among kids and teens. GLP-1 medications, like Ozempic and Wegovy, are drugs originally developed to treat ...
Overpaying for GLP-1 medications is extremely common, with a new data analysis of 102,166 drugs showing that 92% of those prescriptions could have been filled at a lower price. The DoseSpot analysis ...
GLP-1 weight-loss drugs like Ozempic and Zepbound are so effective it might seem that a person can lose weight without doing ...
New study shows GLP-1 weight loss drugs can significantly reduce alcohol intake Neurologist Dr. Leah Croll talks about the new research suggesting they might help in treating people with alcohol ...
The use of behavioral health services decreased dramatically for patients prescribed GLP-1 drugs during the study period.
Head-to-head study shows bariatric surgery superior to GLP-1 drugs for weight loss by American Society for Metabolic and Bariatric Surgery ...
Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found.
CHICAGO -- In patients with type 2 diabetes and obesity, use of GLP-1 receptor agonists was associated with a lower risk of obesity-related cancers and death from any cause, a target trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results